™E Pharma Announces Oral Presentation of NOX-A12 GLORIA Phase 1/2 Trial in Glioblastoma at ESMO Congress 2024 July 17, 2024 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Gold shines as rate cuts beckon, Trump talk hits Taiwan stocks Back: All Posts Next:EssilorLuxottica to Acquire Supreme ® from VF Corporation